1.Status of State Action on the Medicaid Expansion Decision [https://www.kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/?currentTimeframe = 0&sortModel = %7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D]
2.The Coverage Gap: Uninsured poor adults in States that Do Not Expand Medicaid [https://www.kff.org/medicaid/issue-brief/the-coverage-gap-uninsured-poor-adults-in-states-that-do-not-expand-medicaid/]
3.Income & Poverty Data Tables [https://www.census.gov/topics/income-poverty/data/tables.2018.html]
4.Cunningham P, Felland, L.: Environmental Scan to Identify the Major Research Questions and Metrics for Monitoring the Effects of the Affordable Care Act on Safety Net Hospitals. In.: Center for Studying Health System Change; 2013.
5.Institute of Medicine (US) Committee on the Changing Market MC, and the Future Viability of Safety Net Providers: The Core Safety Net and the Safety Net System. In: Americas’s Health Care Safety Net: Intact but Endangered. edn. Edited by Ein Lewin M, Altman S. Washington (DC); 2000.
6.Bonevski B, Randell M, Paul C, Chapman K, Twyman L, Bryant J, Brozek I, Hughes C: Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol 2014, 14:42.
7.Laws R, Gillespie S, Puro J, Van Rompaey S, Quach T, Carroll J, Weir RC, Crawford P, Grasso C, Kaleba E et al: The Community Health Applied Research Network (CHARN) Data Warehouse: a Resource for Patient-Centered Outcomes Research and Quality Improvement in Underserved, Safety Net Populations. EGEMS (Wash DC) 2014, 2(3):1097.
8.Lu Y, Jackson BE, Gehr AW, Cross D, Neerukonda L, Tanna B, Ghabach B, Ojha RP: Affordable Care Act and cancer stage at diagnosis in an underserved population. Prev Med 2019, 126:105748.
9.Stewart RA, MacDonald BR, Chu TC, Moore JD, Fasanmi EO, Ojha RP: Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population. Dig Dis Sci 2018, 63(12):3233–3240.
10.Sutton JP, Washington RE, Fingar KR, Elixhauser A: Characteristics of Safety-Net Hospitals, 2014: Statistical Brief #213. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. edn. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006.
11.Barnett ML, Linder JA, Clark CR, Sommers BD: Low-Value Medical Services in the Safety-Net Population. JAMA Intern Med 2017, 177(6):829–837.
12.Popescu I, Fingar KR, Cutler E, Guo J, Jiang HJ: Comparison of 3 Safety-Net Hospital Definitions and Association With Hospital Characteristics. JAMA Netw Open 2019, 2(8):e198577.
13.Werner RM, Goldman LE, Dudley RA: Comparison of change in quality of care between safety-net and non-safety-net hospitals. JAMA 2008, 299(18):2180–2187.
14.Zuckerman RB, Joynt Maddox KE, Sheingold SH, Chen LM, Epstein AM: Effect of a Hospital-wide Measure on the Readmissions Reduction Program. N Engl J Med 2017, 377(16):1551–1558.
15.Morgenstern H: Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health 1995, 16:61–81.
16.Whitaker RG, Reiter KL, Weinberger M, Stearns SC: Colorectal cancer surgery outcomes for vulnerable patients in safety-net versus non-safety-net hospitals. J Health Care Poor Underserved 2013, 24(2):718–729.
17.Diez-Roux AV: Multilevel analysis in public health research. Annu Rev Public Health 2000, 21:171–192.
18.Members of America’s Essential Hospitals [https://essentialhospitals.org/about-americas-essential-hospitals/listing-of-americas-essential-hospitals-members/]
19.Healthy North Texas- People Living Below Poverty Level, 2013–2017 [http://www.healthyntexas.org/indicators/index/view?indicatorId = 347&localeId = 2794]
20.United States Census Bureau QuickFacts Tarrant County, Texas [https://www.census.gov/quickfacts/tarrantcountytexas]
21.Sharma S. MT, Seals N., Jenkins K., Isaacs M., Anderson RJ: High frequency patient analysis to identify disparities associated with emergency department utilization in Dallas County. Texas Public Health Journal 2017, 69(1):19–29.
22.Chronic Conditions [https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/CC_Main.html]
23.Ross JS, Bernheim SM, Lin Z, Drye EE, Chen J, Normand SL, Krumholz HM: Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood) 2012, 31(8):1739–1748.
24.Gaskin DJ, Hadley J: Population characteristics of markets of safety-net and non-safety-net hospitals. J Urban Health 1999, 76(3):351–370.
25.Salerno AM, Horwitz LI, Kwon JY, Herrin J, Grady JN, Lin Z, Ross JS, Bernheim SM: Trends in readmission rates for safety net hospitals and non-safety net hospitals in the era of the US Hospital Readmission Reduction Program: a retrospective time series analysis using Medicare administrative claims data from 2008 to 2015. BMJ Open 2017, 7(7):e016149.
26.Zuckerman RB, Joynt Maddox KE, Sheingold SH, Chen LM, Epstein AM: Effect of a Hospital-wide Measure on the Readmissions Reduction Program. N Engl J Med 2017, 377(16):1551–1558.
27.Collins SR, Gunja MZ, Doty MM: How Well Does Insurance Coverage Protect Consumers from Health Care Costs? 2017:23.
28.Nguyen OK, Makam AN, Halm EA: National Use of Safety-Net Clinics for Primary Care among Adults with Non-Medicaid Insurance in the United States. PLoS ONE 2016, 11(3):e0151610.
29.Balasubramanian BA, Garcia MP, Corley DA, Doubeni CA, Haas JS, Kamineni A, Quinn VP, Wernli K, Zheng Y, Skinner CS: Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore) 2017, 96(11):e6326.
30.Rosenbaum S: One Nation, Underinsured. Milbank Q 2015, 93(3):463–466.
31.Doktorchik C, Patten S, Eastwood C, Peng M, Chen G, Beck CA, Jette N, Williamson T, Quan H: Validation of a case definition for depression in administrative data against primary chart data as a reference standard. BMC Psychiatry 2019, 19(1):9.
32.Jurek AM, Greenland S, Maldonado G: How far from non-differential does exposure or disease misclassification have to be to bias measures of association away from the null? Int J Epidemiol 2008, 37(2):382–385.
33.Lesko CR, Buchanan AL, Westreich D, Edwards JK, Hudgens MG, Cole SR: Generalizing Study Results: A Potential Outcomes Perspective. Epidemiology 2017, 28(4):553–561.
34.Schmidt AF, Klungel OH, Nielen M, de Boer A, Groenwold RH, Hoes AW: Tailoring treatments using treatment effect modification. Pharmacoepidemiology and drug safety 2016, 25(4):355–362.
35.Stuart EA, Rhodes A: Generalizing Treatment Effect Estimates From Sample to Population: A Case Study in the Difficulties of Finding Sufficient Data. Evaluation review 2016.
36.Stuart EA, Bradshaw CP, Leaf PJ: Assessing the generalizability of randomized trial results to target populations. Prevention science: the official journal of the Society for Prevention Research 2015, 16(3):475–485.
37.Xie Y: Population heterogeneity and causal inference. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(16):6262–6268.
38.National Institutes of Health Revitalization Act of 1993. In., 2d edn; 1993.
39.Burchard EG, Oh SS, Foreman MG, Celedon JC: Moving toward true inclusion of racial/ethnic minorities in federally funded studies. A key step for achieving respiratory health equality in the United States. Am J Respir Crit Care Med 2015, 191(5):514–521.
40.Chen MS, Jr., Lara PN, Dang JH, Paterniti DA, Kelly K: Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials. Cancer 2014, 120 Suppl 7:1091–1096.
41.Ojha RP, Jackson BE, Lu Y, Burton M, Blair SE, MacDonald BR, Chu TC, Teigen KJ, Acosta M: Participation and retention can be high in randomized controlled trials targeting underserved populations: a systematic review and meta-analysis. J Clin Epidemiol 2018, 98:154–157.
42.Katz RV, Kegeles SS, Kressin NR, Green BL, Wang MQ, James SA, Russell SL, Claudio C: The Tuskegee Legacy Project: willingness of minorities to participate in biomedical research. J Health Care Poor Underserved 2006, 17(4):698–715.
43.Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, McMahan V, Bushman LR, Casapía M, Montoya-Herrera O et al: Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 2012, 4(151):151ra125.
44.George S, Duran N, Norris K: A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health 2014, 104(2):e16–31.